More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...

Now, the fight against HIV/AIDS is not just about governments and global health organisations anymore; it is a deeply personal one. And it is all about the choices you make, the conversations you have ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the launch of Choose U™, a new campaign that spotlights the multifaceted experiences of people living with HIV globally. The timing of the campaign ...

Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

A vial of lenacapavir, the new HIV prevention injectable drug that only needs to be administered twice yearly but provides almost complete protection. (Nardus Engelbrecht | AP) The U.S. announced ...

For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...

PurposeMed, which was founded in early 2020, launched Freddie in Canada that July. The service – named after the late rock singer Freddie Mercury – virtually connects patients with nurses or nurse ...

JOHANNESBURG — South Africa on Thursday welcomed a U.S. bridging plan worth $115 million that would continue funding HIV treatment and prevention programs until the end of March, saying it was a sign ...

Shionogi now plans to accelerate its expansion in Europe and the U.S., while pursuing full-scale growth of its new drug ...

The U.S. announced Thursday that it will make an investment in the new HIV prevention drug called lenacapavir that's been hailed as a "breakthrough" and a "game changer" by the medical community. The ...